USPTO serial 90669905
RELARIS
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- NEW APPLICATION PROCESSING
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RELARIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert J. Gorman
1400 N. Goodman StreetLaw DepartmentRochester, NY 14609Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated dermatologic substances and preparations, namely, moisturizers, creams, powders, gels, solutions, shampoos, sprays, swabs, washes, ointments, and topical antibiotics to treat atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses; Non-medicated oral health substances preparations in the form of powders, creams, rinses for the treatment of periodontitis, mouth dryness, cold sores, mouth ulcers | ACTIVE | — |
| 005 | Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, namely, periodontitis, oral mucousitis and bone and soft tissue regeneration; dental rinse for oral health; Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipation, hepatic encephalopathy, irritable bowel syndrome, opioid-induced constipation and ulcerative colitis; Medicated beverages, powders, and gels for colonoscopies and endoscopic procedures; Pharmaceutical preparations and substances to prevent and treat diabetes mellitus, epilepsy, migraines, anxiety and depression, chronic pain, headaches, psychiatric disorders, and rare diseases such as Wilson and Huntington's disease, diabetes mellitus, cardiovascular/angina, hyperammonaemia, hormone deficiencies (endocrinology), cancer, otolaryngology, and urinary tract, lungs, heart infections and diseases, central nervous system disorders, neuromuscular conditions, vaginal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of skin and nail conditions, namely, acne, psoriasis, onychomycosis, tinea pedis, actinic keratosis, rosacea and other dermatoses, fungal infections; Vitamins and mineral supplements | ACTIVE | — |
| 010 | Radio frequency medical devices for contracting skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; Medical devices for aesthetic and therapeutic applications for the skin and its subcutaneous structures, namely, a device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency devices for medical and aesthetic treatment; Medical devices, namely, medical instruments designed for the non-invasive removal of human body fat using an external energy source | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 2, 2021 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Nov 2, 2021 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Nov 1, 2021 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Oct 16, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 16, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 16, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 16, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 16, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 30, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 28, 2021 | NWAP | NEW APPLICATION ENTERED | — |